Large US study confirms that mRNA boosters extend COVID-19 protection but wane over time regenstrief bmj_latest
Separate analyses were done of patients who were admitted to hospital and patients who received care in an emergency department or urgent care clinic .The study population included adults who received care for covid-like illness at a VISION network hospital or emergency department or urgent care center and had molecular testing for SARS-CoV-2 at least 14 days after vaccines became locally available for their age group . The last contact included in this study period occurred on 12 July 2022.
Conditional logistic regression was used to examine case-control status in relation to vaccination status categorized as vaccinated with four, three, or two doses, or partially vaccinated; unvaccinated individuals were used as the reference group. To examine waning of vaccine effectiveness, we categorized people who were vaccinated using time specific indicators defined by two month intervals of time since vaccination; unvaccinated individuals were used as the reference group.
We conducted several sensitivity analyses. First, we added to the study population patients with a known prior infection to assess the sensitivity of results to whether previously infected patients are included or excluded.. Second, we wanted to distinguish results between patients who had been admitted to hospital and patients who had been admitted to an emergency department or to urgent care.
Analyses were conducted with SAS version 9.4 and R version 4.1.2. All confidence limits are 95% intervals. Confidence intervals excluding the null value were considered statistically significant.Study participants contributed in important ways to this research by supplying the underlying data on which the study is based.
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Jacqueline Sullivan opens theatrical design gallery in TriBeCaWallpaper* speaks to gallerist Jacqueline Sullivan as she debuts her TriBeCa space with commissioned works inspired by Gertrude Stein’s poems
Read more »
Lincoln business' open evening raises hundreds for charityAn opportunity for Visual Print & Design to showcase their abilities
Read more »
Palate-Cleansing Fashion Is On The Menu Next SeasonOn the spring/summer 2023 ready-to-wear catwalks at New York, London and Milan Fashion Weeks, the fashion was driven by design DNA. Essence-driven design that acts a palate-cleanser to the overwrought and the extraneously embellished.
Read more »
Nottingham Cathedral restoration awarded £800,000 Lottery grantThe building was designed by Augustus Pugin, who also worked on the design of the House of Commons.
Read more »
Waning of vaccine effectiveness against moderate and severe covid-19 among adults in the US from the VISION network: test negative, case-control studyObjective To estimate the effectiveness of mRNA vaccines against moderate and severe covid-19 in adults by time since second, third, or fourth doses, and by age and immunocompromised status. Design Test negative case-control study. Setting Hospitals, emergency departments, and urgent care clinics in 10 US states, 17 January 2021 to 12 July 2022. Participants 893 461 adults (≥18 years) admitted to one of 261 hospitals or to one of 272 emergency department or 119 urgent care centers for covid-like illness tested for SARS-CoV-2. Main outcome measures The main outcome was waning of vaccine effectiveness with BNT162b2 (Pfizer-BioNTech) or mRNA-1273 (Moderna) vaccine during the omicron and delta periods, and the period before delta was dominant using logistic regression conditioned on calendar week and geographic area while adjusting for age, race, ethnicity, local virus circulation, immunocompromised status, and likelihood of being vaccinated. Results 45 903 people admitted to hospital with covid-19 (cases) were compared with 213 103 people with covid-like illness who tested negative for SARS-CoV-2 (controls), and 103 287 people admitted to emergency department or urgent care with covid-19 (cases) were compared with 531 168 people with covid-like illness who tested negative for SARS-CoV-2. In the omicron period, vaccine effectiveness against covid-19 requiring admission to hospital was 89% (95% confidence interval 88% to 90%) within two months after dose 3 but waned to 66% (63% to 68%) by four to five months. Vaccine effectiveness of three doses against emergency department or urgent care visits was 83% (82% to 84%) initially but waned to 46% (44% to 49%) by four to five months. Waning was evident in all subgroups, including young adults and individuals who were not immunocompromised; although waning was morein people who were immunocompromised. Vaccine effectiveness increased among most groups after a fourth dose in whom this booster was recommended. Conclusions Effecti
Read more »